Avego Bioscience Capital

Portfolio Companies 2026 for Avego Bioscience Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Avego Bioscience Capital accounts for 4 tracked companies with verified cap-table data, 4 of which disclose round sizes totalling $759M. The median disclosed raise is $238M, and the largest is Alentis Therapeutics at $366M, ahead of Escient Pharmaceuticals ($238M) and Evommune ($115M).

The names that recur most often on these portfolio cap tables are Avego Bioscience Capital (4 companies), OrbiMed (2 companies), RA Capital Management (2 companies), PFM Health Sciences (2 companies), Novo Holdings (1 company), Jeito Capital (1 company). By latest disclosed round, the market skews Series C (3), Series D (1).

Best funded Avego Bioscience Capital companies

  1. Alentis Therapeutics — $366M (latest: Series D)
  2. Escient Pharmaceuticals — $238M (latest: Series C)
  3. Evommune — $115M (latest: Series C)
  4. Caribou Biosciences — $40M (latest: Series C)

Avego BioScience Capital GP II, LLC — related firms and companies (56)

Avego BioScience Capital GP II, LLC profile · All research reports